
pmid: 26600102
Sleep disorders are, in part, attributable to genetic variability across individuals. There has been considerable progress in understanding the role of genes for some sleep disorders, such as the identification of a human leukocyte antigen gene for narcolepsy. For other sleep disorders, such as insomnia, little work has been done. Optimizing phenotyping strategies is critical, as is the case for sleep apnea, for which intermediate traits such as obesity and craniofacial features may prove to be more tractable for genetic studies. Rapid advances in genotyping and statistical genetics are likely to lead to greater discoveries in the near future.
Sleep disorder, Insomnia, Sleep apnea, Sleep Apnea Syndromes, Sleep Disorders, Circadian Rhythm, Restless Legs Syndrome, Sleep Initiation and Maintenance Disorders, 2738 Psychiatry and Mental health, Genetics, Humans, Genetic Predisposition to Disease, Restless legs syndrome, Narcolepsy
Sleep disorder, Insomnia, Sleep apnea, Sleep Apnea Syndromes, Sleep Disorders, Circadian Rhythm, Restless Legs Syndrome, Sleep Initiation and Maintenance Disorders, 2738 Psychiatry and Mental health, Genetics, Humans, Genetic Predisposition to Disease, Restless legs syndrome, Narcolepsy
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 29 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
